Literature DB >> 20211234

The pharmacological activities of Compound Salvia Plebeia Granules on treating urinary tract infection.

Miao-Miao Peng1, Yun Fang, Wei Hu, Qing Huang.   

Abstract

AIM OF THE STUDY: Compound Salvia Plebeia Granules (CSPG) had been used for treating urinary tract infection (UTI) for more than 20 years in Drum Tower hospital, but there were lack of sufficient pharmacology studies. The aim of this study was to testify the effects of CSPG on UTI, namely to prove its diuretic, antiblastic, antipyretic and antidynous activities.
MATERIALS AND METHODS: This study evaluated the diuretic effect of CSPG on water load Sprague-Dawley (SD) male rats by the method of metabolic cage, and then analysed the contents of Na(+), K(+), and Cl(-) in urine. The antiblastic activity of CSPG was testified by various kinds of strains in vitro. The antipyretic effect was evaluated by carrageenan-induced fever model in mice. Antidynous activity was demonstrated by the method of acetic acid-induced writhing.
RESULTS: Intragastric (i.g.) administration of CSPG (20-40 g/kg) (equivalent to crude herb) produced a dose-related diuretic effect on water load mice and promoted excreting of Na(+), K(+), and Cl(-) in urine. In addition, the minimal inhibitory concentrations (MICs) of CSPG on Escherichia coli and Staphylococcus aureus were separately 0.25 g/ml and 0.5 g/ml. Moreover, i.g. the doses of CSPG ranging from 25.2 to 50.4 g/kg showed significantly antipyretic effect on carrageenan-induced fever in mice. CSPG (12.6-50.4 g/kg) can also produce dose-related antidynous effects on acetic acid-induced writhing in mice.
CONCLUSIONS: The results described the integrity report of pharmacological studies of CSPG and indicated that it had significantly diuretic, antiblastic, antipyretic, anti-inflammatory and antidynous activities which support its folk medicine use on UTI. (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211234     DOI: 10.1016/j.jep.2010.02.029

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

Review 1.  Chinese herbal medicine for treating recurrent urinary tract infections in women.

Authors:  Andrew Flower; Li-Qiong Wang; George Lewith; Jian Ping Liu; Qing Li
Journal:  Cochrane Database Syst Rev       Date:  2015-06-04

2.  Alternative approaches to conventional treatment of acute uncomplicated urinary tract infection in women.

Authors:  Betsy Foxman; Miatta Buxton
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

3.  Inhibitory effect of Salvia plebeia leaf extract on ultraviolet-induced photoaging-associated ion channels and enzymes.

Authors:  You-Jin Chang; Dong-Ung Lee; Da Yeong Nam; Sung Min Cho; Seungug Hong; Joo Hyun Nam; Woo Kyung Kim
Journal:  Exp Ther Med       Date:  2017-01-05       Impact factor: 2.447

4.  Effects of a herbal formulation, KGC3P, and its individual component, nepetin, on coal fly dust-induced airway inflammation.

Authors:  Evelyn Saba; Young-Sil Lee; Won-Kyung Yang; Yuan Yee Lee; MinKi Kim; Su-Min Woo; KilSoo Kim; Young-Sam Kwon; Tae-Hwan Kim; Dongmi Kwak; Yang-Chun Park; Han Jae Shin; Chang Kyun Han; Jae-Wook Oh; Young Cheol Lee; Hyung-Sik Kang; Man Hee Rhee; Seung-Hyung Kim
Journal:  Sci Rep       Date:  2020-08-20       Impact factor: 4.379

Review 5.  Novel Strategies in the Prevention and Treatment of Urinary Tract Infections.

Authors:  Petra Lüthje; Annelie Brauner
Journal:  Pathogens       Date:  2016-01-27

6.  A Case Report of Poisoning Caused by Incorrect Use of Salvia.

Authors:  Xianyi Yang; Danyang Chen; Lin Chai; Hui Duan; Hui Guo; Shuang Li; Min Xiao; Hongxia Chen
Journal:  Am J Case Rep       Date:  2016-08-15

Review 7.  UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies.

Authors:  Maria E Terlizzi; Giorgio Gribaudo; Massimo E Maffei
Journal:  Front Microbiol       Date:  2017-08-15       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.